P. Forbes William's Insider Trades & SAST Disclosures
P. Forbes William's most recent trade in Heron Therapeutics Inc was a trade of 11,694 Common Stock done . Disclosure was reported to the exchange on April 30, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern P. Forbes William.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Heron Therapeutics Inc | William P. Forbes | EVP, Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2025 | 11,694 | 122,566 (0%) | 0% | - | Common Stock | |
| Heron Therapeutics Inc | P. Forbes William | EVP, Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2025 | 11,694 | 175,416 | - | - | Restricted Stock Units | |
| Heron Therapeutics Inc | William P. Forbes | EVP, Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Apr 2025 | 3,875 | 42,617 | - | - | Restricted Stock Units | |
| Heron Therapeutics Inc | William P. Forbes | EVP, Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Apr 2025 | 3,875 | 110,872 (0%) | 0% | - | Common Stock | |
| Beyond Air Inc | William P. Forbes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2025 | 75,000 | 75,000 | - | - | Stock Options (Right to buy) | |
| Heron Therapeutics Inc | William P. Forbes | EVP, Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 374,220 | 374,220 | - | - | Employee Stock Option (Right to Buy) | |
| Heron Therapeutics Inc | William P. Forbes | EVP, Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 187,110 | 187,110 | - | - | Restricted Stock Units | |
| Heron Therapeutics Inc | William P. Forbes | EVP, Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jan 2025 | 3,874 | 106,997 (0%) | 0% | - | Common Stock | |
| Heron Therapeutics Inc | William P. Forbes | EVP, Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jan 2025 | 3,874 | 46,492 | - | - | Restricted Stock Units | |
| Beyond Air Inc | William P. Forbes | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Nov 2024 | 45,000 | 0 | - | - | Stock Options (Right to buy) | |
| Beyond Air Inc | William P. Forbes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Nov 2024 | 45,000 | 45,000 | - | - | Stock Options (Right to buy) | |
| Beyond Air Inc | William P. Forbes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Nov 2024 | 40,000 | 40,000 | - | - | Stock Options (Right to buy) | |
| Beyond Air Inc | William P. Forbes | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Nov 2024 | 40,000 | 0 | - | - | Stock Options (Right to buy) | |
| Beyond Air Inc | William P. Forbes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Nov 2024 | 30,000 | 30,000 | - | - | Stock Options (Right to buy) | |
| Beyond Air Inc | William P. Forbes | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Nov 2024 | 30,000 | 0 | - | - | Stock Options (Right to buy) | |
| Beyond Air Inc | William P. Forbes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Nov 2024 | 25,000 | 25,000 | - | - | Stock Options (Right to buy) | |
| Beyond Air Inc | William P. Forbes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Nov 2024 | 25,000 | 25,000 | - | - | Stock Options (Right to buy) | |
| Beyond Air Inc | William P. Forbes | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Nov 2024 | 25,000 | 0 | - | - | Stock Options (Right to buy) | |
| Beyond Air Inc | William P. Forbes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Nov 2024 | 25,000 | 25,000 | - | - | Stock Options (Right to buy) | |
| Beyond Air Inc | William P. Forbes | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Nov 2024 | 25,000 | 0 | - | - | Stock Options (Right to buy) | |
| Beyond Air Inc | William P. Forbes | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Nov 2024 | 25,000 | 0 | - | - | Stock Options (Right to buy) | |
| Beyond Air Inc | William P. Forbes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Nov 2024 | 8,000 | 8,000 | - | - | Stock Options (Right to buy) | |
| Beyond Air Inc | William P. Forbes | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Nov 2024 | 8,000 | 0 | - | - | Stock Options (Right to buy) | |
| Heron Therapeutics Inc | William P. Forbes | EVP, Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Oct 2024 | 3,874 | 50,366 | - | - | Restricted Stock Units | |
| Heron Therapeutics Inc | William P. Forbes | EVP, Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Oct 2024 | 3,874 | 103,123 (0%) | 0% | - | Common Stock | |
| Heron Therapeutics Inc | William P. Forbes | EVP, Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jul 2024 | 3,875 | 99,249 (0%) | 0% | - | Common Stock | |
| Heron Therapeutics Inc | William P. Forbes | EVP, Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jul 2024 | 3,875 | 54,240 | - | - | Restricted Stock Units | |
| Heron Therapeutics Inc | William P. Forbes | EVP, Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2024 | 12,500 | 37,500 | - | - | Restricted Stock Units | |
| Heron Therapeutics Inc | William P. Forbes | EVP, Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2024 | 12,500 | 95,374 (0%) | 0% | - | Common Stock | |
| Heron Therapeutics Inc | William P. Forbes | EVP, Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Apr 2024 | 3,874 | 58,115 | - | - | Restricted Stock Units | |
| Heron Therapeutics Inc | William P. Forbes | EVP, Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Apr 2024 | 3,874 | 82,874 (0%) | 0% | - | Common Stock | |
| Beyond Air Inc | P. William Forbes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2024 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
| Heron Therapeutics Inc | Forbes William P. | EVP, Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2024 | 371,935 | 371,935 | - | - | Employee Stock Option (Right to Buy) | |
| Heron Therapeutics Inc | P. Forbes William | EVP, Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2024 | 61,989 | 61,989 | - | - | Restricted Stock Units | |
| Beyond Air Inc | William P. Forbes | Director | Purchase of securities on an exchange or from another person at price $ 6.67 per share. | 31 Mar 2023 | 5,000 | 14,855 (0%) | 0% | 6.7 | 33,350 | Common Stock |
| Beyond Air Inc | William P. Forbes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Beyond Air Inc | William P. Forbes | Director | Purchase of securities on an exchange or from another person at price $ 6.46 per share. | 17 Mar 2023 | 5,000 | 9,855 (0%) | 0% | 6.5 | 32,300 | Common Stock |
| Trevi Therapeutics Inc | William P. Forbes | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2022 | 48,000 | 48,000 | - | - | Performance Stock Options (right to buy) | |
| Beyond Air Inc | William P. Forbes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Trevi Therapeutics Inc | William P. Forbes | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 137,500 | 137,500 | - | - | Stock Option (right to buy) | |
| Beyond Air Inc | William P. Forbes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2021 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Trevi Therapeutics Inc | William P. Forbes | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2021 | 200,000 | 200,000 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges